20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 3051–3060 of 62249 articles for “Art. R. 223-20 and R. 223-22”
…aw no. 83-8 of 7 January 1983 on the division of powers between the communes, départements, regions and the State, the operating cost of training hours and staff costs, the remuneration of trainees an…
In 1994, the allocation mentioned in article R. 4332-3 is distributed between the regions according to the following three criteria: a) 80%, in proportion to the expenditure incurred by the State in 1…
Pharmaceutical establishments and establishments authorised under articles L. 4211-9-1 and L. 4211-9-2 may procure tissues, their derivatives and cells from the human body, whatever their level of pro…
The establishments or organisations mentioned in b of 2° of article R. 1241-31 ensure that the unique donation number that they allocate is unique on the basis of the provisions of the order and good…
…Agence nationale de sécurité du médicament et des produits de santé, pursuant to Article L. 1243-2 and the first and second paragraphs of II of L. 1245-5.II. - The unique European code is allocated a…
…e is allocated by the establishments or organisations authorised under Article L. 1243-2, the first and second paragraphs of II of Article L. 1245-5, the first paragraph of II of article L. 1245-5-1,…
…ystem, any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 : 1° Implements a risk management system for each medicinal product or each product for…
For the medicinal products mentioned in 1° of II of article L. 5121-12 and in II of article L. 5121-12-1, the obligations set out in article R. 5121-161 and articles R. 5121-166 to R. 5121-170 are car…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 shall implement a pharmacovigilance system in order to fulfil its pharmacovigilance obligations…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 is required to: 1° Record all adverse reactions suspected of being due to a medicinal product o…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More
